Thousands in England denied life-extending prostate cancer drug
Thousands of men in England will gain access to the hormone therapy abiraterone for non-metastatic, high-risk prostate cancer starting in January 2026.
The Britain Briefing Engine
Every UK story. Mapped, sourced, and explained where it matters.
News timeline
Last 24 hours
18:20
Thousands in England denied life-extending prostate cancer drug
18:13
Ben Gurion Airport hosts dozens of US Air Force tankers amid Iran conflict
18:06
Dundee City Council warns of planned road closures for maintenance work
17:59
NHS app to introduce AI triage tool to direct patients to services
17:52
FIFA confirms England vs Mexico World Cup kick-off time will not change
17:45
Renters’ Reform Coalition urges next prime minister to introduce rent caps
17:38
Winston Churchill - Wikipedia
17:31
UK energy bills rise by 13 percent as Iran conflict impacts markets
Latest dossiers
All updates
Source trail
Built for search, citation and sharing
Every article keeps its source corpus, primary source, model route, author, timestamp, sitemap trail and verifier record inside the CMS.
